Position
Parallel Advisors, LLC in Dyne Therapeutics, Inc.
Back to the book · All holders of DYN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$38$19.56 → $18.15
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 27 | $528 | — | — | — | 0.0% |
| Q1 2026 | 27 | $490 | $18.15 | −$38 | $0 | 0.0% |